Results 141 to 150 of about 11,434 (195)

Transient paresthesia following polymyxin B loading dose in a critically ill patient: a case report. [PDF]

Ann Med Surg (Lond)
Joshi A, Bogati S, Khakurel S, Acharya S, Kunwor P.   +4 more
europepmc   +1 more source

Pharmacokinetics of polymyxin drugs in special populations. [PDF]

Front Pharmacol
Xu A, Tan Z, Dong L, Liang B, Zhang Z, Cai Y.   +5 more
europepmc   +1 more source

Adaptive résistance to polymyxins in Pseudomonas aeruginosa

, 2015
La résistance aux polymyxines chez P. aeruginosa résulte en partie de la modification du lipide A par addition de 4-amino-aL-arabinose (L-Ara4N), due à l'expression de l'opéron arnBCADTEF-ugD (arn), activée par au moins 6 systèmes de régulation à deux ...
Noguès, Aurélie
core  

Evolution and Antimicrobial Resistance Profiles of <i>Klebsiella</i> spp. Infections in Companion Animals in the Iberian Peninsula. [PDF]

Antibiotics (Basel)
Jiménez-Serrano M, Vidal A, Duran I, Seminati C, Darwich L.   +4 more
europepmc   +1 more source

Safety Profiles of Polymyxins, Aminoglycosides, and Imipenem/Cilastatin/Relebactam (IMI/REL) in the Treatment of Gram-Negative Infections: A Literature Review. [PDF]

Antibiotics (Basel)
Collings H, Stone M, Jha A, Houde FX, D'Adamo F, Waldenberg T, Yücel E.   +6 more
europepmc   +1 more source

Indian Society of Critical Care Medicine Guidelines on Evidence-based Recommendations for the Treatment of Carbapenem-resistant Enterobacterales, Carbapenem-resistant <i>Acinetobacter baumannii</i>, and Carbapenem-resistant <i>Pseudomonas aeruginosa</i> in Critically Ill Patients: A GRADE-guided Approach. [PDF]

Indian J Crit Care Med
Todi SK, Jagiasi BG, Juneja D, Gopaldas JA, Soni KD, Karanth S, Singh R, Kharbanda M, Bhardwaj A, Sahoo TK, Bhosale S, Sinha S, Bharti M, Clerk AM, Kumar A, Rochwerg B, Singh VK, Bhattacharya PK.   +17 more
europepmc   +1 more source

The Auranofin-Colistin Combination Efficiency Against the Gram-Negative Strains: A Review. [PDF]

Infect Drug Resist
Ionescu MI.
europepmc   +1 more source

Treatment of central nervous system infections caused by <i>Pseudomonas aeruginosa</i> with difficult-to-treat resistance: a narrative review. [PDF]

Front Med (Lausanne)
Tao C, Hu Q.
europepmc   +1 more source

Systems-Level Phosphoproteomic and RPPA Profiling Reveals Stress and DNA Damage Signalling as Early Drivers of Polymyxin B Neurotoxicity. [PDF]

Mol Neurobiol
Hussein M, Ansaf TS, Sian TCCLK, Baker M, Faridi P, Kho ZY, Selvakumar N, Kaye KS, Rao GG, Li J, Velkov T.   +10 more
europepmc   +1 more source

Antibiotic development and a path to access in India. [PDF]

Nat Commun
Manesh A, Walia K, Saiyed T, Veeraraghavan B, Paterson DL.   +4 more
europepmc   +1 more source